Peptide-based optical contrast agents for targeting of intestinal malignancies

Niels Röckendorf; Jürgen Helfmann; Naho Fujimoto; Katrin Wehry; Mario Bürger; Andreas Frey

doi:10.1117/12.728404

13 July 2007 Peptide-based optical contrast agents for targeting of intestinal malignancies

Niels Röckendorf, Jürgen Helfmann, Naho Fujimoto, Katrin Wehry, Mario Bürger, Andreas Frey

Proceedings Volume 6633, Biophotonics 2007: Optics in Life Science; 66332A (2007) https://doi.org/10.1117/12.728404
Event: European Conferences on Biomedical Optics, 2007, Munich, Germany

Abstract

Intestinal tumors exhibit cell surface properties that differ from neighboring healthy epithelia and thus allow tumor cell-specific molecular targeting. Ganglioside G_M1 is such a discriminatory target. Although expressed in the apical membrane of all intestinal epithelial cells it is accessible for particle conjugated ligands on tumor cells only. In order to exploit this phenomenon we want to develop a nanoparticulate optical contrast agent equipped with a peptidic G_M1 binding ligand. For identification of ligand peptides a novel screening platform was devised where potential ganglioside GM1-binding peptides are generated on glass capillary plates using microfluidic non-contact arraying techniques and screened in situ for binding of fluorophor-labeled G_M1. These three-dimensional supports are easy to handle and show better sensitivity than either flat glass or membrane supports because of their large inner surface and low interference with readout systems. A custom fluorescence reader was designed to comply with the specific optical behaviour of peptide arrays synthesized on microcapillary plates. This reader uses a small numerical aperture for excitation and a large numerical aperture for detection in epifluorescence-mode. Background noise from fluorescence and Raman scattering is reduced by time gated photon counting. Peptides showing affinity to ganglioside G_M1 will be conjugated to a nano-particulate carrier bearing a fluorescent dye. The resulting optical contrast agent shall be used for fluorescence endoscopic intestinal tumor screening.

Citation Download Citation

Niels Röckendorf, Jürgen Helfmann, Naho Fujimoto, Katrin Wehry, Mario Bürger, and Andreas Frey "Peptide-based optical contrast agents for targeting of intestinal malignancies", Proc. SPIE 6633, Biophotonics 2007: Optics in Life Science, 66332A (13 July 2007); https://doi.org/10.1117/12.728404

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available